Depression among medical outpatients with diabetes: A cross-sectional study at Jos University Teaching Hospital, Jos, Nigeria

Annals of African Medicine

Volumn 9, Issue 1, 2010, Pages 5-10

  Agbir, T M ^a   Audu, M D ^a   Adebowale, T O ^b   Goar, S G ^a  

^a UNIVERSITY OF JOS   (Nigeria)

^b Neuropsychiatric Hospital Aro   (Nigeria)

Author keywords

Depression; Diabetes; Sociodemographic correlates

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HAMILTON SCALE; HOUSEHOLD; HUMAN; INCOME; INTERVIEW; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NIGERIA; OUTPATIENT; OUTPATIENT DEPARTMENT; PREVALENCE; PSYCHIATRIST; QUESTIONNAIRE; RESIDENTIAL AREA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HOSPITALS, TEACHING; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; NIGERIA; OUTPATIENTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES;

EID: 77952079731     PISSN: 15963519     EISSN: 09755764     Source Type: Journal    
DOI: 10.4103/1596-3519.62617     Document Type: Article

References (36)

1. McLarty D. Diabetes in Africa. In: Krall LP, editor. World book on diabetes in practice. Vol 2. Amsterdam: Elsevier Science Publishers; 1986. p. 218-28.
2. King H, Rewels M. WHO Ad Hoc Diabetes Reporting Group: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993;16:157-77. (Pubitemid 23013841)
3. Drury PI, Howlett TA. Endocrinology. In: Kumar P, Clark M, editors. Clinical medicine. A textbook for medical students and doctors. 4th ed. China: Saunders; 1998. p. 957.
4. Johnson TO. Diabetes mellitus in Lagos. Nigeria: (MD thesis) University of London; 1970.
5. National expert committee on non-communicable disease In Nigeria. Preliminary report NCD - Dl 1992. p. 64.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (DSM IV). Washington DC: APA; 1994.
7. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke Bz, Goodwin FK. The de facto US mental and addictive disorders service system: Epidemiological catchment area prospective 1-year prevalence rates of psychiatric disorders and services. Arch Gen Psychiatry 1993;50:85-94.
8. Barrett JE, Barrett lA, Oxman TE, Gerber PD. The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry 1988;45:1100-6. (Pubitemid 19005464)
9. Ciechanowski PS, Koton WJ, Russo JE. Depression and diabetes: Impact of depressive symptoms on adherence, function and cost. Arch Intern Med 2000;160:3278-85.
10. Anderson RJ, Lustman PJ, Clouse RE, Lustman PJ. Prevalence of depression in adults with diabetes: A systematic review. Diabetes 2000; 49: A64.
11. Popkin MK, Collies AL, Lentz RD, Colon EA, Sutherlanrd DE. Prevalence of major depression, simple phobia, and other psychiatry disorders in patients with longstanding type 1 diabetes mellitus. Arch Gen Psychiatry 1988;45:64-8.
12. Coker AO, Ohaeri JU, Lawal RA, Orija OB. Specific psychiatric morbidity among diabetics at a Nigerian General Hospital. East Afr Med J 2000;77:42-5.
13. Akinlade KS, Ohaeri JU, Suberu MA. The psychological conditions of a cohort of Nigeria diabetic subjects. Afr J Med Sci 1996;25:61-7.
14. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes Care 2000;23:934-42. (Pubitemid 30480020)
15. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997;20:585-90. (Pubitemid 27143419)
16. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, et al. Effects of nortriptyline on depression and glucose regulation in diabetes: Results of a double-blind placebo-controlled trial. Psychosom Med 1997;59:241-50.
17. Regier DA, Goldberg ID, Taube CA. The de facto US mental health service systems. Arch Gen Psychiatry 1978;35:685-93.
18. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetin for depression in diabetes: A randomized double-blind placebo-controlled trial. Diabetes Care 2000;23:618-23.
19. World Health Organization. Report of the expert committee on the diagnosis and classification of diabetes mellitus (DCDM). Diabetes Care 1997;20:83-97.
20. Spitzer RL, Williams JB, Gibbon M. Structured Clinical Interview for DSM-1V (SCID). Biometrics Research, New York State Psychiatric Institute, New York: 1987.
21. Riskind JH, Beck AT, Berchick RJ, Brown G, Steer RA. Reliability of DSM III diagnoses for major depression and generalized anxiety disorder using the structured clinical interview for DSM Ill. Arch Gen Psychiatry 1987;44:817-20. (Pubitemid 17152883)
22. Williams JB, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, et al. The Structured Clinical Interview for DSM-ll1-R (SCID) 11: Muti-site test-retest reliability. Arch Gen Psychiatry 1992;49:630-6.
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
24. Danish University Antidepressant Group (DUAG). Citalopram: Clinical effect profile in comparison with clomipramine: A controlled multi centre study. Psychopharmacology 1986;90:131-8.
25. Danish University Antidepressant Group (DUAG). Paroxetin: A selective serotonin reuptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multi centre study. J Affect Dis 1990;18:289-99.
26. Bech P. Rating scales for psychopathology, health status and quality of life. A compendium on documentation in accordance with the DSM-111-R and WHO systems. Berlin: Springler; 1993.
27. Bech P, Malt UF, Dencker SJ, Ahlfors UG, Elgen K, Lewander T, et al. Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand 1993;372:38.
28. Udofia O. SSRI/TCA sequential therapy: A cost effective drug regime for the long term management of depression. Nigerian J Psychiatry 2005;3:33-7.
29. Anumonye A. Clinical assessment of dothiepin. Afr J Psychiatry 1977;3:113-6.
30. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes: An epidemiological evaluation. Diabetes Care 1993;16:1167-78. (Pubitemid 23215405)
31. rd ed. New York: Oxford University Press; 1996. p. 197-244.
32. Kaplan HI, Sadock BJ. Mood disorders. Synopsis of psychiatry: Behavioural sciences and clinical psychiatry 8th edition. Baltimore, Maryland: Williams and Wilkins; 1998. p. 524-73.
33. Blehar M, Oren DA. Gender differences in depression. Medscape Women's Health 1997;2:3. Revised from: Women's increased vulnerability to mood disorders: Integrating psychobiology and epidemiology. Depression 1995;3:3-12.
34. Gregory AN, Jonathan BB. Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care 2003;26:744-9.
35. Faire JD, Heady S, Thomas L, Schechtman K, Fisher EB. Depressive symptomatology and smoking among persons with diabetes. Res-Nurs Health 1994;17:273-82.
36. Engum A, Mykletun A, Midthjell K, Holen A, Dahl A. Depression and diabetes: A large population-based study of sociodemographic, lifestyle, and Clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care 2005;28:1904-9. (Pubitemid 41060961)